Atovaquone, proguanil drug combination
Showing 1 - 25 of >10,000
Malaria Infection Trial in Darmstadt (M5717 60 mg, Pyronaridine, Atovaquone-Proguanil)
Not yet recruiting
- Malaria Infection
- M5717 60 mg
- +4 more
-
Darmstadt, GermanyResearch Site
Aug 2, 2023
Plasmodium Falciparum Malaria (Drug Resistant) Trial in Kratie, Stung Treng, Ânlóng Vêng (Artesunate and Pyronaridine,
Recruiting
- Plasmodium Falciparum Malaria (Drug Resistant)
- Artesunate and Pyronaridine
- +2 more
-
Kratie, Cambodia
- +2 more
Mar 1, 2021
HIV, Malaria Trial in Netherlands (Atovaquone / Proguanil)
Completed
- HIV Infections
- Malaria
- Atovaquone / Proguanil
-
Tilburg, Brabant, Netherlands
- +4 more
Nov 9, 2020
Gastroesophageal Reflux Disease Trial in Seoul (Atovaquone / Proguanil 250/100 mg, Tegoprazan 50 mg, Esomeprazole 40 mg)
Completed
- Gastroesophageal Reflux Disease
- Atovaquone / Proguanil 250/100 mg
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital, Clinical Trial Center
Sep 23, 2021
Malaria Trial in Anlong Veng (atovaquone-proguanil, artesunate-atovaquone-proguanil)
Active, not recruiting
- Malaria
-
Anlong Veng, Oddar Meancheay, CambodiaAnlong Veng Referral Hospital
Mar 1, 2021
Malaria Trial in Bethesda, Silver Spring (Chloroquine-Azithromycin (CQ/AZ), Chloroquine (CQ), atovaquone-proguanil (Malarone®))
Withdrawn
- Malaria
- Chloroquine-Azithromycin (CQ/AZ)
- +2 more
-
Bethesda, Maryland
- +1 more
Feb 25, 2020
Exercise, Pharmacokinetics Trial run by the WRAIR (Malarone)
Withdrawn
- Exercise
- Pharmacokinetics
-
Bethesda, MarylandUniformed Services University
Apr 27, 2021
Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Atovaquone
- +4 more
-
Baltimore, Maryland
- +1 more
Oct 7, 2022
Toxoplasmosis, Cerebral, HIV Trial in United States (Sulfadiazine, Clarithromycin, Atovaquone)
Completed
- Toxoplasmosis, Cerebral
- HIV Infections
- Sulfadiazine
- +4 more
-
Los Angeles, California
- +15 more
Oct 27, 2021
Locally Advanced NSCLC Trial in Edinburgh, London, Oxford (Atovaquone Oral Suspension, Standard of care chemo, Standard of care
Recruiting
- Locally Advanced Non-Small Cell Lung Cancer
- Atovaquone Oral Suspension
- +2 more
-
Edinburgh, United Kingdom
- +1 more
Dec 21, 2021
Ovarian High Grade Serous Adenocarcinoma, Platinum-Resistant Ovarian Carcinoma Trial in Atlanta (Atovaquone, Biopsy, Computed
Not yet recruiting
- Ovarian High Grade Serous Adenocarcinoma
- Platinum-Resistant Ovarian Carcinoma
- Atovaquone
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 11, 2023
Malaria Trial in Croydon (ATV-PG 1000-400 mg + AQ 612 mg)
Completed
- Malaria
- ATV-PG 1000-400 mg + AQ 612 mg
-
Croydon, London, United KingdomRichmond Pharmacology Ltd.
Mar 17, 2020
Plasmodium Falciparum, Malaria Trial in Tübingen (DSM265 400mg, Placebo to DSM265 400 mg, Plasmodium falciparum sporozoite
Completed
- Plasmodium Falciparum, Malaria
- DSM265 400mg
- +3 more
-
Tübingen, GermanyUniversitätsklinikum Tübingen, Institut für Tropenmedizin
Jan 7, 2021
Plasmodium Falciparum Infection Trial in Baltimore (NF54 P. falciparum malaria challenge)
Completed
- Plasmodium Falciparum Infection
- NF54 P. falciparum malaria challenge
-
Baltimore, MarylandUniversity of Maryland School of Medicine - Center for Vaccine D
Jun 3, 2021
Pneumonia, Pneumocystis Carinii, HIV Trial in Puerto Rico, United States (Atovaquone)
Completed
- Pneumonia, Pneumocystis Carinii
- HIV Infections
-
San Francisco, California
- +5 more
Oct 27, 2021
Malaria,Falciparum, Gametocytes, Controlled Human Malaria Infection Trial in Nijmegen (Piperaquine (low dose), Piperaquine (high
Completed
- Malaria,Falciparum
- +3 more
- Piperaquine (low dose)
- +5 more
-
Nijmegen, Gelderland, NetherlandsRadboud university medical center
Jun 15, 2020
Rabies Trial in Syracuse (Chloroquine, Atovaquone and Proguanil, Doxycycline)
Completed
- Rabies
- Chloroquine
- +3 more
-
Syracuse, New YorkState University of New York, Upstate Medical University (SUNY-U
Apr 22, 2021
COVID-19 Trial in Dallas (Experimental Group, Placebo Group)
Completed
- COVID-19
- Experimental Group
- Placebo Group
-
Dallas, TexasUniversity of Texas Medical Center
Dec 12, 2021
NSCLC Trial in Oxford (Atovaquone)
Completed
- Carcinoma, Non-Small-Cell Lung
-
Oxford, Oxfordshire, United KingdomChurchill Hospital
Sep 2, 2019
Malaria Trial (drug, biological, other)
Completed
- Malaria
- atovaquone/proguanil 250mg/100mg (A/P)
- +2 more
- (no location specified)
Jul 11, 2019
Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,
Recruiting
- Relapsed/Refractory Follicular Lymphoma
- Marginal Zone Lymphoma (MZL)
- Odronextamab
- +2 more
-
Chiang Mai, ThailandChiang Mai University
Nov 20, 2023
NSCLC Trial in Houston (Amivantamab, Tepotinib)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023
Pneumonia, Pneumocystis Carinii, HIV Trial in Tanzania, United States (Atovaquone, Dapsone)
Completed
- Pneumonia, Pneumocystis Carinii
- HIV Infections
-
Birmingham, Alabama
- +43 more
Oct 27, 2021